Evaluation of the effectiveness of micronized purified flavonoid fraction (MPFF) as part of the conservative therapy and impact on quality of life and satisfaction with treatment in the real-life clinical practice in patients with haemorrhoids undergoing minimally invasive surgical interventions
Males and females aged over 18 years.
Informing the patient in writing about the inclusion in the study and his/her consent to participate in it.
Absence of conditions requiring urgent medical care.
The patient was diagnosed with chronic hemorrhoids of grade 2 or 3 according to Goligher classification.
Pregnancy or breast-feeding, or planning for pregnancy during the study or at least in two months after its completion.
Confirmed or suspected malignancy.
Severe somatic disorder (of heart or blood vessels, lungs, kidneys, pancreas, or liver), accompanied by the organ function decompensation.
Mental disorder.